HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.

AbstractBACKGROUND:
Previous studies on the efficacy of primary treatments for ductal carcinoma-in-situ (DCIS) have focused on local recurrence rates. Our objective was to detail the outcomes of local invasive recurrence, distant recurrence, and breast cancer mortality in patients previously treated for DCIS.
METHODS:
Clinical, pathologic, and outcome data were collected prospectively for 1236 patients with pure DCIS accrued from 1972 through 2005.
RESULTS:
There were 150 recurrences (87 DCIS and 63 invasive). Invasive local recurrence after mastectomy was rare (0.5% of patients) and after breast preservation was more frequent (12.0% of patients). The 12-year probabilities of breast cancer-specific mortality after mastectomy and after breast preservation were 0.8% and 1.0%, respectively. The 12-year breast cancer-specific mortality and distant disease probability for the 63 patients with invasive recurrences were 12% and 15%, respectively.
CONCLUSIONS:
Regardless of initial treatment, most patients with invasive local recurrence after treatment for DCIS can be treated and cured.
AuthorsLaura A Lee, Melvin J Silverstein, Cathie T Chung, Heather Macdonald, Premal Sanghavi, Melinda Epstein, Dennis R Holmes, Howard Silberman, Wei Ye, Michael D Lagios
JournalAmerican journal of surgery (Am J Surg) Vol. 192 Issue 4 Pg. 416-9 (Oct 2006) ISSN: 0002-9610 [Print] United States
PMID16978940 (Publication Type: Journal Article)
Topics
  • Breast Neoplasms (mortality, pathology, surgery)
  • Carcinoma, Intraductal, Noninfiltrating (mortality, secondary, surgery)
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Mastectomy
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local (mortality, pathology, surgery)
  • Prospective Studies
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: